Tryp Therapeutics Inc (TRYP.CN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [CNSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [CNSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 08/31
(Values in thousands)
| 08-2023 | 08-2022 | 08-2021 | 08-2020 | |
| Assets | ||||
| Current Assets | ||||
| Cash & Cash Equivalents | 345 | 1,796 | 3,692 | 1,019 |
| Receivables | 29 | 6 | 22 | N/A |
| Other current assets | 53 | 86 | 0 | 0 |
| TOTAL | $482 | $2,175 | $4,083 | $1,048 |
| Non-Current Assets | ||||
| Intangibles | 171 | 163 | 25 | 961 |
| Other Non-Current Assets | 0 | 0 | 0 | 27 |
| TOTAL | $171 | $163 | $25 | $987 |
| Total Assets | $653 | $2,339 | $4,108 | $2,035 |
| Liabilities | ||||
| Current Liabilities | ||||
| Short Term Debt | N/A | N/A | N/A | 5 |
| Accounts payable and accrued liabilities | 1,881 | 1,149 | 185 | 141 |
| TOTAL | $1,971 | $1,195 | $185 | $193 |
| Non-Current Liabilities | ||||
| Long Term Debt | 2,103 | N/A | N/A | N/A |
| Other Non-Current Liabilities | 339 | 0 | 0 | 0 |
| TOTAL | $2,442 | $0 | $0 | $0 |
| Total Liabilities | $4,413 | $1,195 | $185 | $193 |
| Shareholders' Equity | ||||
| Common Shares | 13,497 | 13,497 | 9,692 | 2,265 |
| Retained earnings | -21,439 | -16,172 | -8,677 | -423 |
| Other shareholders' equity | 655 | 655 | 0 | 0 |
| TOTAL | $-3,760 | $1,143 | $3,923 | $1,842 |
| Total Liabilities And Equity | $653 | $2,339 | $4,108 | $2,035 |